Research Topics
| Lauren ShaiovaSummaryAffiliation: Mount Sinai School of Medicine Country: USA Publications
|
Detail Information
Publications
Administration of morphine sulfate extended-release capsules via gastrostomy: dissolution study and case reportsLauren Shaiova
Department of Pain Medicine and Palliative Care, Metropolitan Hospital Center, New York, New York 10019, USA
J Palliat Med 10:1063-7. 2007..However, a larger study sample will need to be investigated to determine efficacy in this type of delivery system for cancer pain relief in this population of patients undergoing radiation treatment for head and neck cancers...
Consensus guideline on parenteral methadone use in pain and palliative careLauren Shaiova
Department of Pain Medicine and Palliative Care, Metropolitan Hospital Center, Health and Hospital Corporation of New York City, New York, USA
Palliat Support Care 6:165-76. 2008..The recommendations in this article intend to promote a standard of care involving the use of intravenous methadone with the aim of reaching a broader population of patients for whom this drug would provide important benefits...
Outpatient management of sickle cell pain with chronic opioid pharmacotherapyLauren Shaiova
Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
J Natl Med Assoc 96:984-6. 2004..Pain was well controlled. For each patient, hospital admissions were reduced to < or = 1 visit per year. These reduced levels of ED visits and hospital admissions have remained constant for more than three years...- Measurement of QTc in patients receiving chronic methadone therapyRicardo A Cruciani
Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
J Pain Symptom Manage 29:385-91. 2005..Significant dose response was observed in males on methadone <12 months (rho=0.60, P=0.02). Our study suggests that methadone may prolong the QTc interval in specific subpopulations but poses little risk of serious prolongation... - Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trialRussell K Portenoy
Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
J Pain 13:438-49. 2012..A randomized, double-blind, placebo-controlled, graded-dose study demonstrated efficacy and safety at low and medium doses... - Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositisLauren Shaiova
Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003, USA
Support Care Cancer 12:268-73. 2004..OTFC is effective for breakthrough pain and could be particularly useful in patients with mucositis... - Difficult pain syndromes: bone pain, visceral pain, and neuropathic painLauren Shaiova
Department of Neurology, Division of Pain and Palliative Care, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer J 12:330-40. 2006..Familiarity with opioids, adjuvants, and procedures that can abate pain in cancer patients is discussed in a practical manner for clinical application in this text... - A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipationLauren Shaiova
Department of Neurology, Pain and Palliative Care, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Palliat Support Care 5:161-6. 2007..Methylnaltrexone (MNTX) is a peripheral opioid antagonist currently under clinical investigation. It offers the potential to reverse undesirable side effects without reversing analgesia...